Michael Scolaro

Michael Scolaro

Aug 25, 2017

Group 6 Copy 160
1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Antibiotics and Affect: Avenues for Addiction Management

Addictions to cocaine and other stimulant 'designer' drugs remain unaided by pharmacotherapies. Several...

Does Zika virus replicate in neural cells?

Zika virus is a rapidly emerging virus that is spreading throughout the Western Hemisphere. It is predicted...

Early-Stage Drug Discovery for Chagas' Disease

An estimated 6 – 7 million people in Latin America and 300,000 U.S. citizens are infected with the protozoan...

Backer Badge Funded